Kestra Medical Technologies, Ltd.’s (NASDAQ:KMTS) Quiet Period To Expire on April 15th

Kestra Medical Technologies’ (NASDAQ:KMTS) quiet period will end on Tuesday, April 15th. Kestra Medical Technologies had issued 11,882,352 shares in its public offering on March 6th. The total size of the offering was $201,999,984 based on an initial share price of $17.00. During the company’s quiet period, insiders and underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. The Goldman Sachs Group initiated coverage on shares of Kestra Medical Technologies in a research report on Monday, March 31st. They set a “neutral” rating and a $24.00 target price on the stock. Wells Fargo & Company initiated coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They issued an “overweight” rating and a $28.00 price objective on the stock. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set a “buy” rating and a $28.00 target price for the company. Bank of America initiated coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued a “buy” rating and a $30.00 price target on the stock. Finally, Piper Sandler initiated coverage on Kestra Medical Technologies in a report on Monday, March 31st. They set an “overweight” rating and a $27.00 price objective for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Kestra Medical Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $27.67.

Kestra Medical Technologies Stock Performance

Shares of NASDAQ KMTS opened at $23.85 on Thursday. Kestra Medical Technologies has a 52 week low of $20.00 and a 52 week high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.